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Abstract
Skeletal muscle atrophy is a debilitating condition associated with weakness, fatigue, and reduced functional capacity.
Nuclear factor-kappaB (NF-kB) transcription factors play a critical role in atrophy. Knockout of genes encoding p50 or the
NF-kB co-transactivator, Bcl-3, abolish disuse atrophy and thus they are NF-kB factors required for disuse atrophy. We do
not know however, the genes targeted by NF-kB that produce the atrophied phenotype. Here we identify the genes
required to produce disuse atrophy using gene expression profiling in wild type compared to Nfkb1 (gene encodes p50) and
Bcl-3 deficient mice. There were 185 and 240 genes upregulated in wild type mice due to unloading, that were not
upregulated in Nfkb12/2 and Bcl-32/2 mice, respectively, and so these genes were considered direct or indirect targets of
p50 and Bcl-3. All of the p50 gene targets were contained in the Bcl-3 gene target list. Most genes were involved with
protein degradation, signaling, translation, transcription, and transport. To identify direct targets of p50 and Bcl-3 we
performed chromatin immunoprecipitation of selected genes previously shown to have roles in atrophy. Trim63 (MuRF1),
Fbxo32 (MAFbx), Ubc, Ctsl, Runx1, Tnfrsf12a (Tweak receptor), and Cxcl10 (IP-10) showed increased Bcl-3 binding to kB sites in
unloaded muscle and thus were direct targets of Bcl-3. p50 binding to the same sites on these genes either did not change
or increased, supporting the idea of p50:Bcl-3 binding complexes. p65 binding to kB sites showed decreased or no binding
to these genes with unloading. Fbxo9, Psma6, Psmc4, Psmg4, Foxo3, Ankrd1 (CARP), and Eif4ebp1 did not show changes in
p65, p50, or Bcl-3 binding to kB sites, and so were considered indirect targets of p50 and Bcl-3. This work represents the first
study to use a global approach to identify genes required to produce the atrophied phenotype with disuse.
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Introduction
Skeletal muscle atrophy is a highly regulated process in which
the size of a multinucleated fiber is controlled by signaling that
regulates gene expression from triggers in the muscle [1,2]. One
group of signaling proteins that regulate muscle atrophy is the
nuclear factor-kappaB (NF-kB) family of transcription factors. A
role for NF-kB in adult muscle atrophy or wasting has been found
in aging [3,4], disuse [5,6,7,8], denervation [9,10], muscular
dystrophy [11,12], and cachexia due to illnesses such as cancer
[10,13,14]. NF-kB transcription factors (p65, c-Rel, RelB, p52,
p50) act as dimers that bind target genes that have been shown to
regulate cellular processes as diverse as immunity, inflammation,
development, cell proliferation, and apoptosis [15,16,17].
In the case of disuse atrophy, NF-kB is necessary for muscle
fiber wasting. Evidence for this comes from data showing that a
NF-kB reporter is strongly activated in muscle fibers at 3, 7, and
10 days of disuse by hind limb unloading [5,7,8]. Inhibition of
components of upstream NF-kB regulatory proteins such as the
overexpression of a super repressor form of the inhibitor of kB
(IkBa SR) showed a 40% inhibition of fiber atrophy [5], and
overexpression of either a dominant negative (d.n.) form of IkB
kinase beta (IKKb) or a d.n. form of IKKa each showed a 50%
inhibition of fiber atrophy and a complete abolition of unloading
induced NF-kB reporter [6]. Importantly, a 70–100% inhibition of
muscle fiber atrophy was found in mice lacking either the Nfkb1
gene (encodes the NF-kB transcription factor, p50) or the Bcl-3
gene, which encodes a NF-kB co-transactivator [7]. Gel supershift
assays and nuclear levels of p65, p52, and RelB do not suggest
significant involvement of these NF-kB family members [8]. Rel
knockout mice showed that c-Rel is not required for disuse atrophy
[5]. An important feature of NF-kB activation in disuse-induced
atrophy is that there is no evidence of inflammation or
complement activation [8,18,19] as is seen with other types of
muscle atrophy such as that due to primary muscle disease,
systemic illness, or aging [20]. When inflammation is associated
with muscle wasting, involvement of the prototypical NF-kB
family member p65 (Rel A) has been evident [3,4,10,11,12,13,20].
Although we have found that upstream signaling proteins, such
as IkBa, IKKa and IKKb that activate NF-kB transcription are
required for atrophy, we do not understand how NF-kB
transcription factors produce the atrophied phenotype. We do
know that the transcription factors p50 and Bcl-3 are essential for
atrophy during disuse [7], so in the present study we first identified
the genes being targeted by p50 and Bcl-3, thereby identifying
genes that are required to produce the atrophied phenotype in
each case. To do this we performed global gene expression analysis
of plantar flexor muscles from weight bearing and hind limb
unloaded wild type mice and compared these data to the same
muscles from Nfkb12/2 mice and from Bcl32/2 mice. This
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provided a list of genes required for atrophy, and that are
considered either direct or indirect targets of p50 and Bcl-3 during
atrophy. From the lists we selected genes to study in further detail
to determine whether p50 and/or Bcl-3 showed increased binding
to kB binding sites using chromatin immunoprecipitation (ChIP)
assays in weight bearing and unloaded mouse plantar flexor
muscles. An advantage of using gene expression profiling in
combination with ChIP assays is that they reflect mRNA
expression and DNA binding in vivo, at the moment of isolation.
A gene showing increased mRNA expression in wild type muscle
but not in knockout muscle due to unloading and that shows an
increase in p50 and/or Bcl-3 binding in wild type unloaded muscle
is evidence that a p50 or Bcl-3 direct target gene has been
identified.
This work represents the first study to use a global approach to
identify the genes required to produce the atrophied phenotype
due to muscle unloading. Identification of genes that are NF-kB
targets is a first step in the discovery of how these transcription
factors produce the atrophied phenotype during skeletal muscle
disuse.
Results
Muscle Atrophy
There was an 18% decrease in gastrocnemius plus plantaris
muscle mass for wild type 6-day hind limb unloaded mice (wet
weight normalized to body weight), but there were little to no
differences for the same muscles in the Nfkb12/2 or Bcl-32/2 mice
(Table S1). This is consistent with the atrophy we reported
previously in plantaris muscles due to 10 days of unloading in wild
type mice, but little to no differences in plantaris muscle atrophy in
the Nfkb12/2 or Bcl32/2 mice [7].
Microarray analysis of muscle from wild type and
knockout mice to identify direct or indirect targets of p50
and Bcl-3 in atrophy
A major aim of this study was to identify genes from the
atrophied phenotype with unloading. Since Nfkb12/2 or Bcl-32/2
mice showed little or no atrophy with unloading [7], finding the
genes that drive the atrophy process was accomplished by
identifying those genes that were upregulated in the unloaded
muscles from wild type mice but not upregulated in the unloaded
muscles from Nfkb12/2 or Bcl-32/2 mice. The reason for focusing
on upregulated genes is that previous work showed a marked
upregulation of NF-kB dependent binding and transcription in
atrophying muscles [7,8]. The expression data for up and down-
regulated genes due to hind limb unloading for all 3 strains of mice
(wild type, Nfkb12/2, Bcl32/2) have been deposited in the
MIAME compliant Gene Expression Omnibus (http://www.
ncbi.nlm.nih.gov/geo/), accession number GSE23497.
Using the statistical methods described below, we identified
upregulated genes in 6-day unloaded muscle in wild type but not in
knockout mice. There were 185 genes upregulated in wild type mice
but not in Nfkb12/2 mice due to unloading and these genes were
thus considered either direct or indirect targets of the p50
transcription factor during muscle atrophy (Table S2). Functional
classification of these genes was made based on the molecular
function and biological processes annotated by the Gene Ontology
Consortium (Table 1). Most genes were involved in signaling (15%),
translation (10%), metabolism (10%), protein degradation (9%),
transcription (8%), and transport (6%). The same approach was
used to identify direct or indirect targets of Bcl-3 using Bcl32/2
mice. This produced a list of 240 genes that were direct or
indirect targets (Table S2) of this transcriptional co-activator that
is known to bind p50 dimers to induce transcription [21,22,23].
These genes also belong largely to signaling (13%), metabolism
(10%), translation (9%), protein degradation (9%), transcription
(8%), and transport (8%) (Table 1). Upregulation of genes in these
functional categories is consistent with the changes seen in other
studies using microarray data to describe muscle atrophy [18,24].
Selected Genes for Further Study as p50/Bcl-3 Targets
From the microarray data, we identified 25 upregulated genes
that were targets of p50 and/or Bcl-3 and that have at least some
known or inferred function in muscle atrophy (Table 2). All but 6
of these 25 genes are involved in some aspect of protein
degradation. Seven are involved in ubiquitination of protein
substrates (Fbxo32, Fbxo9, Fbxo36, Ubc, Ube2j1, Nedd4l, Cul4a), 9
encode proteasomal subunits (Psma7, Psmb3, Psmc4, Psmd2, Psmd13,
Psmb4, Psmd4, Psmg4, Psma6), 2 are lysosomal genes (Ctsl, Ctss), and
one is involved in calpain mediated protein cleavage (Capns1).
There were 4 genes whose protein product can act as a
transcription factor (Ankrd1 (Carp), Runx1, Jun, Foxo3), a gene
encoding a translational repressor (Eif4ebp1), and the Tweak
cytokine receptor (Tnfrsf12a). Twelve of these 25 genes, a
representative sampling of the functional groups, plus 2 other
genes that were not on the microarray, Trim63 (MuRF1) and
Cxcl10 (IP-10), were chosen for study in more detail (14 genes
total).
Quantitative real-time PCR of selected atrophy genes
Quantitative real-time PCR (qPCR) confirmed significant
upregulation by unloading of the 14 genes selected for further
study and their lack of upregulation in knockout mice (Figure 1).
Table 1. Functional category of target genes for Bcl-3 and
p50 from microarray analysis.
Bcl3 targets p50 targets
Number Percentage Number Percentage
Signaling 31 12.92% 28 15.14%
Metabolism 24 10.00% 18 9.73%
Translation 22 9.17% 19 10.27%
Protein degradation 21 8.75% 17 9.19%
Transcription 21 8.75% 16 8.65%
Transport 19 7.92% 12 6.49%
Non-annotated or
RIKEN cDNA
14 5.83% 9 4.86%
Misc: immune/
proliferation/ECM
13 5.42% 11 5.95%
RNA processing 12 5.00% 9 4.86%
Cytoskeleton 11 4.58% 9 4.86%
Chromatin modification 10 4.17% 7 3.78%
Cell adhesion 7 2.92% 6 3.24%
Structure 7 2.92% 5 2.70%
Development 7 2.92% 4 2.16%
Cell cycle 6 2.50% 4 2.16%
Binding 5 2.08% 4 2.16%
Anti-oxidant 4 1.67% 3 1.62%
Muscle contraction 3 1.25% 3 1.62%
Stress 3 1.25% 1 0.54%
doi:10.1371/journal.pone.0016171.t001
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Many of these genes are involved in ubiquitin-proteasome
mediated protein degradation, namely, Trim63 (MuRF1), Fbxo32
(MAFbx), Ubc, Fbxo 9, Psma6, Psmc4, and Psmg4 (Figure 1A–G).
Other genes whose microarray data were confirmed by qPCR and
that play a role in muscle atrophy were Ctsl, Foxo3, Runx1, Ankrd1,
Tnfrsf12a, and Eif4ebp1 (Figure 1H–M). The Trim63 gene was not
on our microarray but has a significant role in muscle atrophy
[25,26,27,28]. Another gene not on the microarray, Cxcl10 (IP-10),
was also studied (Figure 1N) because it was found to be strongly
upregulated in unpublished work and in response to TNFa; it is a
known p50:Bcl-3 target in immune cells [29]. Almost all genes
were shown to be direct or indirect targets of Bcl-3 and p50 since
there was either no upregulation, or significantly less upregulation,
in unloaded muscles from Bcl32/2 and Nfkb12/2 mice compared
to unloaded muscles from wild type mice. The exceptions were
Fbxo9 and Foxo3, which showed upregulation in unloaded muscle
of Nfkb12/2 mice similar to that of wild type mice (Figure 1D, I),
so these two genes were not confirmed targets of p50 during
unloading. GAPDH did not change with unloading in wild type or
mutant mice and so it was used for normalization of all the
mRNAs measured by qPCR (Figure 1O).
Chromatin Immunoprecipitation (ChIP) of selected p50
or Bcl-3 putative target genes
For genes that were direct or indirect targets of p50 and Bcl-3
with muscle unloading, we performed ChIP assays using muscle
from wild type mice to assess whether there was a commensurate
change in p50 and Bcl-3 binding to NF-kB binding sites due to
muscle unloading. For comparison, we also measured changes in
the prototypical NF-kB transcription factor family member, p65,
because there are not definitive data as to whether it is involved in
NF-kB dependent gene regulation by muscle unloading as there is
with Bcl-3 and p50. To identify putative kB binding sites in each
gene to be studied, an algorithm called CLOVER [30] was used to
search for sites in the genomic sequence from 10kb upstream of
each gene’s transcription start site (TSS) to 10kb downstream from
its polyadenylation signal.
Of the 14 genes on which a ChIP assay was performed, 11 had
conserved kB sites. The other 3 genes contained kB sites, but
none were conserved (Fbxo9, Psmg4, Eif4ebp1); not surprisingly,
these 3 genes did not show changes in binding of the 3 kB factors
studied, due to unloading. The most frequent and robust change
in protein binding to kB sites of the 3 transcription factors studied
was Bcl-3. There was an increase in Bcl-3 binding to conserved
kB sites in 7 of the 14 genes studied. These were Fbxo32 (the site
550bp upstream of the TSS), Trim63 (the site in the third intron
4.8 kb downstream of the TSS), Ubc (the site 1.4 kb upstream of
the TSS), Ctsl (the site 5.5 kb upstream of the TSS), Runx1 (the
site 1.7 kb upstream of the TSS), Tnfrsf12a (the site 5.7 kb
upstream of the TSS), and Cxcl10 (the two sites 157 bp upstream
of the TSS) (Figure 2A–G). Of these 7 genes, p50 binding to the
same kB site was either unchanged or, it was increased in Trim63,
Runx1, and Cxcl10. In all 7 genes, the increased Bcl-3 binding to
sites where p50 was bound suggests increased formation of p50-
Bcl-3 complexes with unloading. For p65 binding there were
marked decreases in 4 genes, Fbxo32, Trim63, Ctsl, and Cxcl10
(Figure 2A, B, D, G) and no detectable binding in control or
unloaded muscle in Ubc or Runx1 (Figure 2C, E). The fact that no
kB site showed marked p65 binding with unloading supports
earlier work suggesting that p65 is not a major player in disuse
muscle atrophy [8]. There was a moderate increase in p65
binding in one gene, Tnfrsf12a (Figure 2F). Each immunoprecip-
itation was repeated with different muscles from weight bearing
and unloaded groups.
The proteasome subunit genes studied, Psmc4, Psmg4, and Psma6
(Figure 2H–J), and located 1.9, 2.7, and 3.2kb upstream from the
TSS, respectively, were not direct kB target genes since p65, p50
or Bcl-3 showed no change in binding. The kB sites studied in
Fbxo9, Ankrd1, Foxo3, and Eif4ebp1 (Figure 2K–N) genes, located at
1.2, 2.3, 2.0, and 2.7kb upstream of the TSS, respectively, also did
not show significant changes in binding of Bcl-3, p50, or p65.
None of these 7 genes appear to be direct p50 or Bcl-3 target
genes.
Discussion
This study is the first to identify on a global scale, direct or
indirect target genes of two transcription factors previously shown
to be required for muscle disuse atrophy, p50 and Bcl-3 [7]. This
was done using gene expression profiling of unloaded skeletal
muscle from wild type mice compared to unloaded muscle from
Table 2. Selected genes with known or inferred functions in
muscle atrophy that were target genes for Bcl-3 and/or p50.
Probe ID Gene Symbol FC in WT Bcl-3 Target p50 Target
Ubiquitination
1417522_at Fbxo32 2.9 Y Y
1432211_a_at Fbxo9 1.8 Y N
1419305_a_at Fbxo36 2.4 Y Y
1425966_x_at Ubc* 1.8 Y Y
1448824_at Ube2j1 1.6 Y Y
1423269_a_at Nedd4l 1.5 Y Y
1451971_at Cul4a 1.5 Y Y
Proteasomal subunits
1423568_at Psma7 1.5 Y Y
1460198_a_at Psmb3 1.5 Y Y
1416290_a_at Psmc4 1.5 Y Y
1415831_at Psmd2 1.5 Y Y
1422459_a_at Psmd13 1.5 Y Y
1438984_x_at Psmb4 1.4 Y Y
1425859_a_at Psmd4 1.4 Y Y
1435431_at Psmg4 1.4 Y Y
1435317_x_at Psma6 2.3 Y Y
Lysosomal proteins
1451310_a_at Ctsl 1.6 Y Y
1448591_at Ctss 1.5 Y Y
Transcription factors
1420992_at Ankrd1 7.9 Y Y
1422864_at Runx1 5.3 Y Y
1417409_at Jun 1.7 Y Y
1434832_at Foxo3* 1.6 Y Y
Others
1418572_x_at Tnfrsf12a 2.7 Y Y
1434976_x_at Eif4ebp1 1.6 Y Y
1426400_a_at Capns1 1.5 Y Y
FC= ‘‘fold change’’ of gene expression in weight bearing vs. hind limb unloaded
groups in wild type animals from microarray analysis. Y = a target gene for Bcl-3
or p50, N = not a target gene for Bcl-3 or p50.
*gene significantly increased by t-test but did not pass multiple test correction.
doi:10.1371/journal.pone.0016171.t002
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mice deficient for the gene encoding each of these transcription
factors. Genes in wild type mice upregulated by hind limb
unloading that are not upregulated in unloading of knockout mice
are either direct or indirect targets of the gene knocked out. Since
our previous work shows a complete atrophy inhibition when the
genes encoding p50 and Bcl-3 are knocked out, it is not surprising
to have a significant number (,200) of genes that are targets of
these transcription factors. In combination with these data, we
performed ChIP assays on kB sites in 14 of the kB -upregulated
genes (verified by qPCR) to assess whether they were direct targets
of p50 and Bcl-3. We focused on upregulated genes because disuse
elicits an increase in NF-kB binding to DNA and a robust increase
in NF-kB dependent transcription in unloaded muscle from rats
and mice [5,6,7,8].
Figure 1. Quantitative real time PCR (qPCR) to measure mRNA expression of selected atrophy genes. Taqman probe and primer sets
were used to confirm mRNA expression from microarray data of gastrocnemius and plantaris muscles. All 14 genes measured confirmed a significant
upregulation due to 6 days unloading (HU) compared to weight bearing (WB) in muscles of wild type (WT) mice. Gene expression due to unloading in
knockout mice (Nfkb1 and Bcl-3) was either not different from weight bearing or it had a significantly less increase for all cases except Fbxo9 and
Foxo3 in Nfkb12/2mice. Gene expression was measured for: A) Trim63 (MuRF1), B) Fbxo32 (MAFbx), C) ubiquitin C, D) Fbxo9, E) Psma6, F) Psmc4, G)
Psmg4, H) Ctsl, I) Foxo3, J) Runx1, K) Ankrd1 (Carp), L) Tnfrsf12a (Tweak receptor), M) Eif4ebp1, N) Cxcl10 (IP-10), and O) GAPDH. *significantly
different from weight bearing value (P,0.05), {significantly different from wild type unloaded value (P,0.05).
doi:10.1371/journal.pone.0016171.g001
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The microarray and ChIP results show that Fbxo32, Trim63,
Ubc, Ctsl, Runx1, Tnfrsf12a, and Cxcl10 are direct gene targets of
Bcl-3 during disuse atrophy because of their lack of mRNA
upregulation in Bcl-32/2 mice with unloading and the increase in
Bcl-3 binding to conserved kB sites in unloaded muscles of wild
type mice. Since Bcl-3 does not directly bind DNA, we presume
that it bound to existing p50 binding at the kB site under study. All
genes studied showed p50 binding in control muscle, and with
unloading, p50 binding either did not change or increased in the 7
genes where Bcl-3 binding was increased. We interpret these data
to indicate the formation of p50:Bcl-3 complexes. Other data
supporting the idea of p50 and Bcl-3 working together to effect
gene expression changes with unloading is that all of the p50
targets revealed by the microarray data were also Bcl-3 target
genes. Moreover, the increase in NF-kB reporter activity due to
unloading in wild type mice is absent in unloaded muscle from
Nfkb12/2 and Bcl-32/2 mice [7]. In unloaded muscle, binding of
the prototypical kB protein p65 decreased markedly or was not
detectable in all but one of these 7 genes. Taken together, these
data suggest p50:Bcl-3 complexes are important proteins binding
to kB sites during muscle atrophy. There is a significant literature
on the ability of p50 homodimers to induce transactivation when
bound to Bcl-3 in several non-muscle cell types [21,22,23].
There was a marked increase in Bcl-3 binding to conserved kB
sites in 4 upregulated genes with known roles in protein
degradation with muscle atrophy. Thus, they are direct targets
of kB. These are Fbxo32 [28,31] Trim63 [25,26,28], Ubc
[18,24,28,32], and Ctsl [5,24,33]. Although we now clearly show
that p50 and Bcl-3 target these genes and that NF-kB is required
for their upregulation, there may be other factors involved. For
instance, FoxO3 was shown to target Fbxo32 during starvation
atrophy [34]. FoxO1 has been shown to target Ctsl during
starvation atrophy and regulate its transcription [33]. NF-kB was
shown to target Trim63 in skeletal muscle in cachexia [10] and the
present work supports these data in atrophying muscle due to
unloading, although we show a role for p50 and Bcl-3 rather than
involvement of p65.
It was interesting however, that three of the nine proteasomal
genes shown to be targets of p50 and Bcl-3, and chosen for further
study, were indirect rather than direct kB target genes because
there was no change in p65, p50, or Bcl-3 binding with unloading.
This supports the idea that proteasomal subunit upregulation with
atrophy is directly regulated by transcription factors other than
NF-kB, although NF-kB may be regulating these unknown factors
based on the gene expression data in the knockout mice.
Another direct target gene of NF-kB proteins is Runx1,
previously shown to moderate myofibrillar stabilization and
autophagy during disuse atrophy [35]. It is a transcription factor
with 29 putative gene targets in atrophying muscle. These targets
appear to be mostly structural genes, distinct from the structural
unloading-induced kB target genes. While kB regulates Runx1,
Runx1 activity does not seem to involve activation of FoxO or NF-
kB-mediated transcription during disuse muscle atrophy [35]. We
show that Bcl-3 and p50 have structural gene targets (Table S1)
Figure 2. ChIP assays of Bcl-3, p50, and p65 protein binding to genes from Figure 1. ChIP assay was performed using gastrocnemius/
plantaris muscle from weight bearing (WB) and unloaded (HU) mice. For each gene shown, binding of Bcl-3, p50 and p65 protein to a kB binding site
was measured. ChIP showed an increase in Bcl-3 protein binding to 7 of the 14 genes studied, these were: A) Fbxo32, B) Trim63, C) Ubc, D) Ctsl, E)
Runx1, F) Tnfrsf12a, and G) Cxcl10. There were also increases in p50 (B, E, G) and decreases in p65 (A, B, D, G) in these 7 genes. None of the
proteasomal subunit genes showed changes in Bcl-3, p50, or p65 binding, Psmc4., Psmg4, or Psma6 (H–J). Fbxo9, Ankrd1, Foxo3, and Eif4ebp1 (K–N)
genes also did not show changes in the binding of these proteins to kB sites. For each gene, ChIP assays were repeated using different samples from
WB and HU groups. The PCR product size for all 14 ChIP assays performed was between 190 to 400bp.
doi:10.1371/journal.pone.0016171.g002
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and some of these share the same functional category (e.g.,
channels, contractile proteins) as targets of Runx1 but none were
the same genes as described by Wang et al. [35].
The Tnfrsf12a gene was unique among the 14 genes studied for
ChIP as it showed an increase in Bcl-3 binding, a moderate
increase in p50 binding, and increased p65 binding. The lack of
increased p65 binding to putative kB sites in all but one of the 14
genes studied by ChIP is consistent with previous work suggesting
a lack of primary involvement of p65 in unloading atrophy [8]. On
the other hand, dominant negative overexpression of either IkBa
SR, IKKa, or IKKb inhibited unloading atrophy by ,50%
suggesting that p65 may be involved in regulating some atrophy
genes. In the case of Tnfrsf12a, regulation via kB proteins may
involve a complex of p65:p50:Bcl-3 binding as previously
described in response to TNFa [29].
Tnfrsf12a, found to be a direct kB target is a receptor for a
member of the TNF superfamily also known as TWEAK. This
cytokine receptor is of interest as it has recently been shown to be
increased with denervation atrophy [36]. In addition, TWEAK is
known to induce muscle wasting in whole muscle [37] and it was
required for denervation atrophy [36]. As with other pro-
inflammatory cytokines, NF-kB is involved in mediating the
wasting due to TWEAK in skeletal muscle [37]. We show here
that the upregulation of the TWEAK receptor requires kB
proteins. Whether unloading also involves TWEAK binding to its
receptor is not yet clear.
IP-10 was also found to be a direct kB target with unloading. It is
a chemokine and a known NF-kB target gene in non-muscle cells
types [29,38]. The strong upregulation of this gene together with the
robust increase in p50 and Bcl-3 binding to IP-10 in unloaded
muscle suggest there may be some role for immunemodulator genes
in this type of atrophy. In control muscle there was significant p65
binding to IP-10 but this was undetectable at 6 days of unloading. In
response to TNFa however, p65 binding to bona fide kB sites is
increased [29]. The IP-10 and Tnfrsf12a data suggest further study
of selected chemokines and cytokines/receptors in unloading
atrophy. Consistent with previous work however [7,8], the present
data supports the idea that in the absence of inflammatory response
[19], p65 does not appear to have a major role in binding kB sites on
atrophy genes, in contrast with its involvement in atrophy when
inflammatory triggers are involved [4,10,13].
From these studies we have created a list of NF-kB regulated
genes in unloading atrophy, and, we determined that at least 7 of
the 14 genes studied in detail using ChIP are direct targets of, p50
and Bcl-3. These data in combination with the lack of increases in
p65 binding at kB sites in 13 of the 14 upregulated genes studied,
again suggests a primary role of p50 and Bcl-3 rather than the
canonical NF-kB transcription factor, p65 (RelA). There are very
likely other transcription factors required for unloading atrophy;
gene regulation is created by interactions of several factors in
complexes or in separate sites on the promoter and regulatory
regions. However, it is clear that loss of either of these kB proteins
in the knockout animals eliminates or profoundly reduces the
atrophy produced by unloading and therefore our candidate list
not only outlines the scope of genes whose products create muscle
wasting, but it gives us the keystone genomic sites of regulation
with which we will be able to understand disuse atrophy at the
molecular genetic level.
Materials and Methods
Mice and Hind limb Unloading
Six week-old male wild type mice (B6129PF2/J) and age/sex
matched Nfkb12/2 mice (B6;129P2-Nfkb1tm1Bal/J) and Bcl32/2
mice (FVB; 129P2-Bcl3tm1Ver/J) were purchased from the Jackson
Laboratory (Bar harbor, ME). The B6129PF2/J strain used for
wild type has all of the 129 background which was part of the
knockout cloning and insertion (the embryonic stem cell
background) for each of these mutants. Animals were provided
with chow and water ad libitum and housed individually in Boston
University Animal Care Facility. After 3 days of acclimation, mice
were randomly assigned to weight-bearing (WB) or hind limb
unloaded (HU) groups. Mice in the HU group had their hind
limbs elevated off the cage floor for 6 days to induce unloading
induced muscle atrophy. The sixth day of unloading is a key point
in the atrophy process based on a large literature, and in particular
based on a previous time course study we performed on unloaded
rat soleus muscle [18].
The HU was performed using the methods that we have
previously published [39] with slight modifications for the mice.
Briefly, mice were lightly anesthetized with ketamine/xylazine
(40mg/kg;5mg/kg, i.p.). A strip of adhesive foam pad (ALIMED
Inc, MA) was folded in half and the adhesive surface was loosely
applied longitudinally along the proximal 2/3 of the tail. Elastic
tape (Elastoplast, Medco Supply Co., NY) was wrapped
circumferentially around the adhesive foam. A wire was passed
through the folded end of adhesive foam pad and then was drawn
up to pulley attached to a 360u swivel hook at the top of the cage;
the cage walls were extended in height by 10 inches of Plexiglas on
4 sides to allow room for the vertical suspension. The length of the
wire was adjusted so that the toes of the hind limbs touched the
cage floor only during full hind limb extension. The use of animals
in this study was approved by the Institutional Animal Care and
Use Committee of Boston University (protocol number 09-012).
Muscle harvesting and RNA isolation
Six days after hind limb unloading, mice were anesthetized with
ketamine/xylazine (100mg/kg; 13mg/kg). Gastrocnemius and
plantaris muscles were harvested from weight bearing and hind
limb unloaded wild type mice, Nfkb12/2 mice, and Bcl32/2 mice
and processed immediately for RNA isolation or ChIP assay. Total
RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad,
CA) according to manufacturer’s instructions. Extracted total
RNA was treated with RNase-Free DNase I (Qiagen, Valencia,
CA) to remove any DNA contamination and purified using an
RNeasy Mini kit (Qiagen, Valencia, CA) as previously described
[40]. Total RNA was quantified by absorption spectrophotometry
at 260 and 280nm and quality of total RNA was monitored on a
1% denaturing agarose gel and by a Bioanalyzer 2100 (Agilent,
Palo Alto, CA).
Microarray processing
For microarray analysis 24 mice were used based on 4 mice per
group, 3 mouse stains, and 2 conditions (weight-bearing and
unloaded). Total RNA samples (n = 4 per group) were sent to
Partners HealthCare Center for Personalized Genetic Medicine
for mRNA labeling, hybridization, and scanning using the
Affymetrix system (Santa Clara, CA). In brief, double stranded
cDNA was synthesized by GeneChipH Two-Cycle cDNA
Synthesis Kit (P/N 900432). Biotin-labeled cRNA was then
generated and purified by GeneChip IVT labeling kit (P/N
900449) and cRNA Cleanup kit (P/N 900547). 15mg of labeled
fragmented cRNA was hybridized on to Affymetrix GeneChip
Mouse Genome 430A 2.0 Array, then washed and stained
according to manufacturer’s protocol. The 430A 2.0 Array
measures expression levels of 14,000 characterized genes. The
microarray slides were scanned using a GeneChipH Scanner 3000.
For data extraction and quality control, Affymetix GeneChipH
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operation software was used, which created a single intensity value
for each probe-set assayed in each sample in a .cel file. Data files
were deposited into the MIAME compliant NCBI Gene Ex-
pression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/),
accession number GSE23497.
Data Analysis
Affymetrix .cel files were imported into GenePattern software
3.2.1 (Broad Institute, Cambridge, MA) and a matrix containing
an expression value per probe set for each sample was generated
by Expression File Creator Module using the Robust Multi-array
Average (RMA) algorithm and quantile normalization [41]. Gene
probes were filtered according to the following criteria: maximum
expression value/minimum expression value $1.7, minimum
expression variation (maximum value2minimum value) $9,
expression value greater than 20 or less than 20,000. Genes
complying with these criteria were further processed by the
ComparativeMarkerSelection Module Version7. By default,
ComparativeMarkerSelection compared the mean difference in
gene expressions between weight bearing and unloaded muscle
samples using two-way parametric t-tests and computed false
discovery rate for each probe set using the Q-value [42]. P-
value,0.05 and q-value#0.05 were used to identify genes that
were significantly differentially expressed after hind limb unload-
ing.
We also carried out analyses for the wild type vs. knockouts in
the weight bearing condition as a control for any change in gene
expression that might arise from the knockout itself. We found no
significant differences in muscle gene expression in wild type vs.
Bcl32/2, but 17 genes in the Nfkb12/2 case were lower than wild
type. Only one of those 17 was in our list of genes that could be a
target of p50 and so it was removed from our results.
Quantitative Real time-PCR (QRT-PCR)
Total RNA from 3 strains of mice (two knockouts and one wild
type) for 2 conditions (WB and HU) was isolated as described
above with a sample size of 6 per group. 10mg of total RNA was
reverse transcribed in a 100ml reaction using a High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems, Foster
City, CA) according to manufacturer’s instructions. Synthesized
cDNA (0.9 ml) was then amplified with Taqman Gene Expression
Master mix, and gene-specific TaqMan Gene Expression Assay
Buffer (Applied Biosystems). The sequence targeted by each
TaqMan probe is given in Table S3. Amplification was performed
by ABI 7300 Real-Time PCR System at following temperature:
50uC for 2min, 95uC for 10min, followed by 40 cycles at 95uC for
15sec and 60uC for 1min. All samples were run in triplicate and
quantified according to the corresponding gene-specific standard
curve. For the 14 genes for which we measured mRNA expression,
each gene was normalized to GAPDH expression, which was not
different due to mouse strain or to hind limb unloading.
Statistical Analysis
Methods used for statistical analysis of the microarray data have
been described above. All other statistical analysis was performed
using the SPSS software package for windows version 15.0 (SPSS
Inc, Chicago, IL). For qPCR experiments (n = 6 per group),
Levene’s test was first performed to compare the variance between
weight bearing and hind limb unloaded muscles. If 2 groups
showed an equal variance, an equal-variance t-test was performed
to determine whether gene expression was upregulated after
unloading. If 2 groups showed unequal variance, an unequal-
variance t-test was performed. P-value less than 0.05 was
considered statistically significant.
ChIP Procedure
Isolation of nuclei from muscle and subsequent successful ChIP
assay is infrequent in the literature and methods details are scarce.
Our method begins with a modification of Andrews et al. [43].
Gastrocnemius plus plantaris muscles from weight bearing and
hind limb unloaded mice were removed, weighed, and immersed
in 1 ml of the nuclear isolation buffer (NIB: 10mM of HEPES
pH7.5, 10mM MgCl2, 60mM KCl, 300mM sucrose, 0.1mM
EDTA pH8.0, 0.1% Triton X-100, 1mM DTT, 0.15mM
spermine and 0.5mM spermidine, 0.1mM PMSF, 2mg/ml
aprotinin, 2mg/ml leupeptin). The muscle was finely minced using
sterile scalpels and transferred to a 1.5 ml Eppendorf tube. The
minced muscle was crosslinked by adding fresh formaldehyde to a
final concentration of 1% and rotating at room temperature (RT)
for 15 minutes. Crosslinking was stopped by adding glycine to a
final concentration of 0.125M and rotating at RT for 5 minutes.
Tubes were centrifuged at 15006g for 5 minutes at 4uC and
washed twice with PBS containing 16 protease inhibitor cocktail
[(PIC), Roche Applied Bioscience]. After the last spin, the
supernatant was discarded and the pellet was snap frozen in
liquid nitrogen and stored at 280uC. After thawing, each pellet
was suspended in 1.5 ml of NIB, transferred to a 14 ml round
bottom tube (BD Falcon), and homogenized mechanically. The
homogenates were centrifuged at 1806g for 1 minute and
supernatants discarded. Pellets were re-suspended in 1.5 ml NIB
and homogenized again to maximize the number of nuclei
released from myofibrillar material. Homogenates from both legs
of the same mouse were pooled and passed though a 100 mm cell
strainer (BD Falcon) by centrifugation at 11006g for 5 minutes at
4uC to filter residual myofibrillar material from the nuclei. The
filter process was repeated with a 40 mm cell strainer (BD Falcon),
and then nuclei pelleted by centrifugation at 11006g for
5 minutes. Each cell strainer was then washed twice with 2 ml
of ice cold PBS containing 16PIC, then centrifuged to pellet any
nuclei stuck in the strainer.
The nuclei were processed for ChIP using modifications of the
method described by Tachibana et al. [44]. Nuclei were re-
suspended in sonication buffer with PIC. Aliquots of 350 to 400 ml
were sonicated with a Sonic Dismembrator Model 100 (Fisher) at
setting 2 for 30 seconds with one minute in between on ice, for 9
to 12 cycles. Nuclear debris was pelleted by spinning the sonicated
material at maximum speed in a microfuge for 5 minutes, and the
supernatant containing fragmented chromatin was saved for
immunoprecipitation. The extent of sonication was evaluated by
removing 10 ml supernatant for treatment with Pronase, RNase A,
and reverse crosslinked, and then DNA was extracted with
phenol/chloroform and precipitated with ethanol. DNA was size
fractionated on a 1% agarose gel where approximately 90% of the
DNA was visualized as a smear between 100–600 bp. Equal
amounts of fragmented chromatin from each group, weight
bearing and hind limb unloaded, were diluted in IP dilution buffer
[44] and pre-cleared twice using the Protein G conjugated
magnetic beads (Dynabeads, Invitrogen) that had been blocked
overnight with BSA and sonicated fish sperm DNA (Roche
Applied Bioscience). The beads were pelleted by centrifugation
and the supernatant containing the chromatin was aliquoted: a
100 ml aliquot as an input sample not immunopreciptated, and
four aliquots with equal amount of the remaining supernatant
(,700–1000 ml each). One aliquot was incubated with IgG as a
negative control and the other three chromatin aliquots were
immunoprecipitated by incubation with 10 mg of antibody (Santa
Cruz), directed against either p65 (SC-372X), p50 (SC-1190X), or
Bcl3 (SC-185X) for 16 hours at 4uC. The antibody-chromatin
complexes were warmed to RT in a water bath and an equal
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volume of pre-blocked magnetic beads was added and placed on a
rotator for 15 minutes at RT. The tubes were then placed in a
magnetic tube rack (Magnasphere separation stand, Promega) to
allow capture of beads on the side of the tube. The liquid was
removed and beads were washed in a succession of buffers
according to Tachibana et al. [44]. Finally the conjugates were
eluted from the beads for 30 minutes. The protein and RNA were
removed from the immunoprecipitated samples and the input
sample by incubation with Pronase and RNase A for 2 hrs at
42uC. The sample and input tubes were processed to reverse the
crosslinking and DNA was precipitated in ethanol with glycogen as
carrier. The DNA from ChIP was re-suspended in 30 ml of Tris-
low EDTA buffer (10 mM Tris 8.0, 0.1 mM EDTA). For PCR, 1/
15th of the each DNA sample and 1/100th of each input were used
as templates in a standard Platinum Taq PCR reaction for 32
cycles. PCR products were separated on a 10% TBE gel (Ready
Gel, BioRad) and stained by SYBR Gold.
NF-kB sites for study were selected by the CLOVER algorithm
of Motifviz (http://biowulf.bu.edu/MotifViz/), which uses the
JASPAR database (http://jaspar.genereg.net/) for its binding
matrices. We selected kB sites for ChIP that had the best score for
matching the kB consensus sequence using the JASPAR matrix
ID: MA0061.1. Conservation between mouse and human gene
sequences was determined by locating the kB site in the mouse
genome using Blat and displaying the comparative sequences at
that site in the University of California Santa Cruz gene browser
(http://genome.ucsc.edu/). Primers were designed with Primer
3.0 from the online workpage (http://frodo.wi.mit.edu/primer3/).
The size of the PCR products containing the kB sites was between
190 and 400bp for all 14 ChIP assays.
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